Your browser doesn't support javascript.
loading
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.
Bradley, Todd; Yang, Guang; Ilkayeva, Olga; Holl, T Matt; Zhang, Ruijun; Zhang, Jinsong; Santra, Sampa; Fox, Christopher B; Reed, Steve G; Parks, Robert; Bowman, Cindy M; Bouton-Verville, Hilary; Sutherland, Laura L; Scearce, Richard M; Vandergrift, Nathan; Kepler, Thomas B; Moody, M Anthony; Liao, Hua-Xin; Alam, S Munir; McLendon, Roger; Everitt, Jeffrey I; Newgard, Christopher B; Verkoczy, Laurent; Kelsoe, Garnett; Haynes, Barton F.
Afiliación
  • Bradley T; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710; todd.bradley@duke.edu garnett.kelsoe@dm.duke.edu barton.haynes@dm.duke.edu.
  • Yang G; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Ilkayeva O; Department of Immunology, Duke University Medical Center, Durham, NC 27710.
  • Holl TM; Department of Pathology, Duke University Medical Center, Durham, NC 27710.
  • Zhang R; Department of Immunology, Duke University Medical Center, Durham, NC 27710.
  • Zhang J; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Santra S; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Fox CB; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215.
  • Reed SG; Infectious Disease Research Institute, Seattle, WA 98102.
  • Parks R; Infectious Disease Research Institute, Seattle, WA 98102.
  • Bowman CM; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Bouton-Verville H; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Sutherland LL; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Scearce RM; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Vandergrift N; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Kepler TB; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Moody MA; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Liao HX; Department of Microbiology, Boston University, Boston, MA 02215.
  • Alam SM; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • McLendon R; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710.
  • Everitt JI; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Newgard CB; Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
  • Verkoczy L; Department of Medicine, Duke University Medical Center, Durham, NC 27710.
  • Kelsoe G; Department of Pathology, Duke University Medical Center, Durham, NC 27710.
  • Haynes BF; Department of Pathology, Duke University Medical Center, Durham, NC 27710.
J Immunol ; 197(12): 4663-4673, 2016 12 15.
Article en En | MEDLINE | ID: mdl-27849170
ABSTRACT
The HIV-1 envelope protein (Env) has evolved to subvert the host immune system, hindering viral control by the host. The tryptophan metabolic enzyme kynureninase (KYNU) is mimicked by a portion of the HIV Env gp41 membrane proximal region (MPER) and is cross-reactive with the HIV broadly neutralizing Ab (bnAb) 2F5. Molecular mimicry of host proteins by pathogens can lead to autoimmune disease. In this article, we demonstrate that neither the 2F5 bnAb nor HIV MPER-KYNU cross-reactive Abs elicited by immunization with an MPER peptide-liposome vaccine in 2F5 bnAb VHDJH and VLJL knock-in mice and rhesus macaques modified KYNU activity or disrupted tissue tryptophan metabolism. Thus, molecular mimicry by HIV-1 Env that promotes the evasion of host anti-HIV-1 Ab responses can be directed toward nonfunctional host protein epitopes that do not impair host protein function. Therefore, the 2F5 HIV Env gp41 region is a key and safe target for HIV-1 vaccine development.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Péptidos / Triptófano / Proteína gp41 de Envoltorio del VIH / Infecciones por VIH / VIH-1 / Vacunas contra el SIDA / Hidrolasas Idioma: En Revista: J Immunol Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Péptidos / Triptófano / Proteína gp41 de Envoltorio del VIH / Infecciones por VIH / VIH-1 / Vacunas contra el SIDA / Hidrolasas Idioma: En Revista: J Immunol Año: 2016 Tipo del documento: Article